119 related articles for article (PubMed ID: 37925954)
1. Tracking the binding site of anticancer drug fluxoridin with Fe-related proteins to achieve intelligent drug delivery.
Shahraki S; Delarami HS; Razmara Z; Heidari A
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Feb; 306():123569. PubMed ID: 37925954
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of deferasirox on the structure and function of bovine liver catalase: a spectroscopic and theoretical study.
Moradi M; Divsalar A; Saboury AA; Ghalandari B; Harifi AR
J Biomol Struct Dyn; 2015; 33(10):2255-66. PubMed ID: 25586906
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for multiple ligand recognition by the human transferrin receptor.
Giannetti AM; Snow PM; Zak O; Björkman PJ
PLoS Biol; 2003 Dec; 1(3):E51. PubMed ID: 14691533
[TBL] [Abstract][Full Text] [Related]
4. Ferric ions release from iron-binding protein: Interaction between acrylamide and human serum transferrin and the underlying mechanisms of their binding.
He F; Wang J; Yuan D; Liu Y; Liu R; Zong W
Sci Total Environ; 2022 Nov; 847():157583. PubMed ID: 35882343
[TBL] [Abstract][Full Text] [Related]
5. Studies on the binding of fulvic acid with transferrin by spectroscopic analysis.
Zhang XF; Yang G; Dong Y; Zhao YQ; Sun XR; Chen L; Chen HB
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1280-5. PubMed ID: 25305622
[TBL] [Abstract][Full Text] [Related]
6. Interaction of imatinib mesylate with human serum transferrin: The comparative spectroscopic studies.
Śliwińska-Hill U
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():468-475. PubMed ID: 27718450
[TBL] [Abstract][Full Text] [Related]
7. Activation of catalase by pioglitazone: Multiple spectroscopic methods combined with molecular docking studies.
Yekta R; Dehghan G; Rashtbari S; Sheibani N; Moosavi-Movahedi AA
J Mol Recognit; 2017 Dec; 30(12):. PubMed ID: 28626866
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional changes of catalase through interaction with Erlotinib hydrochloride. Use of Chou's 5-steps rule to study mechanisms.
Shahraki S; Samareh Delarami H; Poorsargol M; Sori Nezami Z
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Nov; 260():119940. PubMed ID: 34038867
[TBL] [Abstract][Full Text] [Related]
9. A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides.
Güette-Fernández JR; Meléndez E; Maldonado-Rojas W; Ortega-Zúñiga C; Olivero-Verbel J; Parés-Matos EI
J Mol Graph Model; 2017 Aug; 75():250-265. PubMed ID: 28609757
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic studies of the interaction mechanisms between mono-caffeoylquinic acids and transferrin.
Guan Y; Dong J; Chen S; Liu M; Wang D; Zhang X; Wang H; Lin Z
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 181():82-90. PubMed ID: 28342427
[TBL] [Abstract][Full Text] [Related]
11. Effects of Resveratrol on the Structure and Catalytic Function of Bovine Liver catalase (BLC): Spectroscopic and Theoretical Studies.
Rashtbari S; Dehghan G; Yekta R; Jouyban A; Iranshahi M
Adv Pharm Bull; 2017 Sep; 7(3):349-357. PubMed ID: 29071216
[No Abstract] [Full Text] [Related]
12. Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms.
Kleven MD; Jue S; Enns CA
Biochemistry; 2018 Mar; 57(9):1552-1559. PubMed ID: 29388418
[TBL] [Abstract][Full Text] [Related]
13. Elucidation on inhibition and binding mechanism of bovine liver catalase by nifedipine: multispectroscopic analysis and computer simulation methods.
Zhou L; Zhou H; Xiao H; Zhang Z; Xiong Z; Tuo X; Guo H
Luminescence; 2022 Sep; 37(9):1547-1556. PubMed ID: 35816002
[TBL] [Abstract][Full Text] [Related]
14. Study on the interaction of a cyanine dye with human serum transferrin.
Zhang XF; Chen L; Yang QF; Li Q; Sun XR; Chen HB; Yang G; Tang YL
Luminescence; 2015 Dec; 30(8):1176-83. PubMed ID: 25736560
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.
Farnaud S; Amini M; Rapisarda C; Cammack R; Bui T; Drake A; Evans RW; Suryo Rahmanto Y; Richardson DR
Int J Biochem Cell Biol; 2008; 40(12):2739-45. PubMed ID: 18691669
[TBL] [Abstract][Full Text] [Related]
16. Cobalt and the iron acquisition pathway: competition towards interaction with receptor 1.
Chikh Z; Hémadi M; Miquel G; Ha-Duong NT; El Hage Chahine JM
J Mol Biol; 2008 Jul; 380(5):900-16. PubMed ID: 18579154
[TBL] [Abstract][Full Text] [Related]
17. Specific binding and inhibition of 6-benzylaminopurine to catalase: multiple spectroscopic methods combined with molecular docking study.
Xu Q; Lu Y; Jing L; Cai L; Zhu X; Xie J; Hu X
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Apr; 123():327-35. PubMed ID: 24412785
[TBL] [Abstract][Full Text] [Related]
18. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
19. Catalytic activity and structural changes of catalase in the presence of Levothyroxine and Isoxsuprine hydrochloride.
Shahraki S; Delarami HS; Saeidifar M; Nejat R
Int J Biol Macromol; 2020 Jun; 152():126-136. PubMed ID: 32045611
[TBL] [Abstract][Full Text] [Related]
20. Unraveling Binding Mechanism of Alzheimer's Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases.
Shamsi A; Mohammad T; Khan MS; Shahwan M; Husain FM; Rehman MT; Hassan MI; Ahmad F; Islam A
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31533274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]